We are live on ! Find out more
CCM

Cullen Capital Management Portfolio holdings

AUM $9.75B
1-Year Est. Return 21.81%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$3.85B
AUM Growth
+$155M
Cap. Flow
-$23.5M
Cap. Flow %
-0.61%
Top 10 Hldgs %
32.64%
Holding
238
New
38
Increased
42
Reduced
43
Closed
30

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$69.4M
2
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$29.5M
3
JPM icon
JPMorgan Chase
JPM
+$4.17M
4
MET icon
MetLife
MET
+$4.11M
5
GE icon
GE Aerospace
GE
+$4.1M

Top Sells

Rank Stock Value
1
D icon
Dominion Energy
D
+$66M
2
AZN icon
AstraZeneca
AZN
+$56.1M
3
EQNR icon
Equinor
EQNR
+$26.1M
4
MMM icon
3M
MMM
+$6.47M
5
MO icon
Altria Group
MO
+$6.38M

Sector Composition

Rank Sector Weight
1 Healthcare 13.67%
2 Energy 12.43%
3 Financials 10.98%
4 Technology 10.92%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COP icon
1
ConocoPhillips
COP
$144B
$142M 3.69%
1,658,290
+20
+0% +$1.56K
INTC icon
2
Intel
INTC
$413B
$134M 3.48%
4,333,450
-750
-0% -$20.6K
LLY icon
3
Eli Lilly
LLY
$1.08T
$130M 3.37%
2,085,050
– –
RDS.B
4
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$128M 3.32%
1,467,830
+354,550
+32% +$29.5M
MRK icon
5
Merck
MRK
$322B
$124M 3.21%
2,237,826
-113,236
-5% -$6.18M
MSFT icon
6
Microsoft
MSFT
$2.9T
$123M 3.18%
2,941,130
+950
+0% +$38.4K
JNJ icon
7
Johnson & Johnson
JNJ
$640B
$122M 3.17%
1,168,220
+200
+0% +$20.2K
MMM icon
8
3M
MMM
$91.8B
$122M 3.16%
1,015,727
-55,136
-5% -$6.47M
BCE icon
9
BCE
BCE
$20.8B
$117M 3.04%
2,584,220
+45,900
+2% +$2.07M
RTN
10
DELISTED
Raytheon Company
RTN
$116M 3.02%
1,261,260
+400
+0% +$38.8K
TRV icon
11
Travelers Companies
TRV
$81.1B
$116M 3.01%
1,232,730
+34,000
+3% +$3.1M
MO icon
12
Altria Group
MO
$125B
$113M 2.93%
2,692,780
-158,700
-6% -$6.38M
CVX icon
13
Chevron
CVX
$382B
$113M 2.93%
863,180
+31,050
+4% +$3.86M
GE icon
14
GE Aerospace
GE
$364B
$112M 2.92%
893,184
+32,234
+4% +$4.1M
CSCO icon
15
Cisco
CSCO
$443B
$109M 2.83%
4,383,350
+900
+0% +$21.5K
JPM icon
16
JPMorgan Chase
JPM
$916B
$105M 2.72%
1,820,030
+74,240
+4% +$4.17M
MET icon
17
MetLife
MET
$62.4B
$97.5M 2.53%
1,969,144
+87,909
+5% +$4.11M
T icon
18
AT&T
T
$164B
$97.2M 2.52%
3,638,021
+119,425
+3% +$3.2M
DD
19
DELISTED
Du Pont De Nemours E I
DD
$97.1M 2.52%
1,562,757
+600
+0% +$38.6K
NEE icon
20
NextEra Energy
NEE
$184B
$93.7M 2.43%
3,657,920
-128,120
-3% -$3.12M
UN
21
DELISTED
Unilever NV New York Registry Shares
UN
$89M 2.31%
2,032,810
– –
HSBC icon
22
HSBC
HSBC
$352B
$84.6M 2.2%
1,932,895
– –
KMB icon
23
Kimberly-Clark
KMB
$37.6B
$83.8M 2.18%
785,901
– –
PM icon
24
Philip Morris
PM
$309B
$80.4M 2.09%
953,380
– –
WELL icon
25
Welltower
WELL
$173B
$76.8M 1.99%
1,224,670
+300
+0% +$18.9K
1
2 3 4 5

Similar funds

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Cullen Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Cullen Capital Management held 238 positions worth $3.85B, up 4.2% from $3.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Cullen Capital Management's Q2 2014 filing shows 38 new, 42 increased, 43 reduced and 30 closed positions. Its largest new stake was Pfizer: 2,436,353 shares worth $68.6M. The largest sale was Dominion Energy, an estimated $66M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Energy and Financials.

  • Cullen Capital Management's largest Q2 2014 buy was Pfizer: 2,436,353 shares worth $68.6M.
  • Cullen Capital Management added most to Royal Dutch Shell PLC ADS Class B in Q2 2014, an estimated $29.5M increase.
  • Cullen Capital Management's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $56.1M.
  • Cullen Capital Management fully exited Dominion Energy in Q2 2014, selling an estimated $66M.
  • Cullen Capital Management's ten largest holdings make up 33% of its $3.85B portfolio in Q2 2014.
  • Cullen Capital Management opened 38 new positions and closed 30 in Q2 2014.
  • Cullen Capital Management's portfolio value rose 4.2% quarter-over-quarter to $3.85B.

Based on Cullen Capital Management's 13F filing for Q2 2014, filed 11 Aug 2014.